Clinical Trial Update: Endostar Combination With Chemotherapy for the Metastatic Nasopharyngeal Carcinoma [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial from Zhejiang Cancer Hospital is evaluating Endostar in combination with chemotherapy for metastatic nasopharyngeal carcinoma. The curr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nasopharyngeal Carcinoma

Drugs mentioned

• Endostar (recombinant human endostatin)

Snippet

Sponsor: Zhejiang Cancer Hospital | Conditions: Nasopharyngeal Carcinoma | Phase 2 | Status: UNKNOWN